Sulfasalazine Market Size and Growth Rate?
As per Data Bridge Market Research analysis, the Sulfasalazine Market was valued at USD 428.0 million in 2025 and is projected to reach USD 627.5 million by 2033, growing at a CAGR of 4.90% from 2026 to 2033.
The market is experiencing steady growth driven by sulfasalazine's sustained role as a low-cost, first-line conventional DMARD for rheumatoid arthritis and as a maintenance therapy for inflammatory bowel disease, alongside its continued inclusion on the WHO Model List of Essential Medicines.
𝐕𝐢𝐬𝐢𝐭 𝐮𝐬 𝐧𝐨𝐰 -
Persistently high global prevalence of rheumatoid arthritis and inflammatory bowel disease, combined with sulfasalazine's continued affordability relative to biologic therapies, continues to sustain demand. Recent stabilization of generic manufacturer supply, following a shortage period that began in 2020, is expected to further support consistent market growth.